Seegene was introduced as a company that has produced unique molecular diagnostic technologies and products in the bio-health sector, one of Korea’s key future industries, and is currently competitive enough to stand should to shoulder with global companies. By showing the diagnostic procedure of a university hospital that uses Seegene’s multiplex molecular diagnostic products, the documentary provided a glimpse into a future in worldwide, and it was also an example and suggestion for the future direction of a health care-based Korean economy, which is especially meaningful in light of Korea’s current rapid transitioning into an aging society.
In his interview, CEO Jong-Yoon Chun based his comments on the Seegene corporate motto, saying, “The goal of Seegene is the popularization of molecular diagnostics. ‘Molecular diagnostics’ is still unfamiliar to most people, but all it really refers to is a type of examination that leads to an accurate medical diagnosis. For a patient facing a life-or-death situation, what could be more important than a prompt and accurate diagnosis? Seegene promises to create a world in which life is better for both doctors and patients.”
Most developed countries have already implemented remote examination systems, in which a patient verifying their own physical condition and be examined by a doctor without leaving the house.
The Korean biotechnology market is still in its infancy, but there is hope that companies like Seegene can bring better health and hope to humanity through globally-recognized molecular diagnostic technology